A Population‐Based Approach to the Argument on Brain‐First and Body‐First Pathogenesis of Lewy Body Disease
Annals of Neurology · 2024
DOI: 10.1002/ana.27006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2024. Verfasst von Emanuele Camerucci und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Lewy Body Disease, Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Objective
To explore the clinical progression of the brain‐/body‐first categories within Lewy body disease (LBD): Parkinson's disease (PD), dementia with Lewy bodies (DLB), and PD dementia.
Methods
We used of the Rochester Epidemiology Project to establish a population‐based cohort of clinically diagnosed LBD. We used two definitions for differentiating between brain‐ and body‐first LBD: a previously hypothesized body‐first presentation in patients with rapid eye movement sleep behavior onset before motor symptoms onset; and an expanded definition of body‐first LBD when a patient had at least 2 premotor symptoms between constipation, erectile dysfunction, rapid eye movement sleep behavior, anosmia, or neurogenic bladder.
Results
Brain‐first patients were more likely to be diagnosed with PD (RR = 1.43, p = 0.003), whereas body‐first patients were more likely to be diagnosed with DLB (RR = 3.15, p < 0.001). Under the expanded definition, there was no difference in LBD diagnosis between brain‐first and body‐first patients (PD: RR = 1.03, p = 0.10; DLB: RR = 0.88, p = 0.58) There were no patterns between brain‐ or body‐first presentation, PD dementia under either definition (original: p = 0.09, expanded: p = 0.97), and no significant difference in motor symptoms between brain‐first and body‐first.
Interpretation
Our findings do not support the dichotomous classification of body‐first and brain‐first LBD with the currently proposed definition. Biological exposures resulting in PD and DLB are unlikely to converge on a binary classification of top‐down or bottom‐up synuclein pathology. ANN NEUROL 2024;96:551–559
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Neurology, Kansas University Medical Center (KUMC), Kansas City, KS, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
- Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
ORCID-Profile: Rodolfo Savica
Zitieren
APA
Camerucci, E., Mullan, A. F., Turcano, P., Stang, C. D., Bower, J., Benarroch, E. E., Boeve, B. F., & Savica, R. (2024). A Population‐Based Approach to the Argument on Brain‐First and Body‐First Pathogenesis of Lewy Body Disease. Annals of Neurology. https://doi.org/10.1002/ana.27006
Vancouver
Camerucci E, Mullan AF, Turcano P, Stang CD, Bower J, Benarroch EE, et al. A Population‐Based Approach to the Argument on Brain‐First and Body‐First Pathogenesis of Lewy Body Disease. Annals of Neurology. 2024. doi:10.1002/ana.27006
BibTeX
@article{Camerucci2024,
author = {Camerucci, Emanuele and Mullan, Aidan F and Turcano, Pierpaolo and Stang, Cole D and Bower, James and Benarroch, Eduardo E and Boeve, Bradley F and Savica, Rodolfo},
title = {A Population‐Based Approach to the Argument on Brain‐First and Body‐First Pathogenesis of Lewy Body Disease},
journal = {Annals of Neurology},
year = {2024},
doi = {10.1002/ana.27006}
}
EUVIMED